ATEC
Alphatec Holdings, Inc.
NASDAQ · USHealthcareMedical - Devices
$8.27-3.10%
Price as of Jul 20, 2026
ATEC growth
Alphatec Holdings, Inc. growth
Reported trailing growth, forward expectations and three-year compound growth rates.
Trailing growth
Year over year
- Revenue
- +22.5%
- EBITDA
- +97.4%
- EBIT
- +58.8%
- EPS
- +27.8%
- Free cash flow
- +108.6%
- Operating cash flow
- +558.2%
Forward estimates
- Revenue
- +21.7%
- EBITDA
- —
- EPS
- +137.1%
Three-year CAGR
- Revenue
- +29.6%
- EBITDA
- +26.3%
- EBIT
- +39.7%
- Net income
- +11.6%
- EPS
- +15.0%
- Free cash flow
- +102.0%
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.